investigated the therapeutic potential of S100A8/A9 blockade in the context of sepsis-induced myocardial dysfunction, highlighting the critical role of S100A8/A9 in mediating both myocardial and systemic inflammation in sepsis. Here, IGKV1D-22 is linked to Sepsis.